ASU 2011-06

The objective of this Update is to address questions about how health insurers should recognize and classify in their income statements fees mandated by the Patient Protection and Affordable Care Act as amended by the Health Care and Education Reconciliation Act (the Acts). Those questions were raised in comment letters received on the proposed Accounting Standards Update, Other Expenses (Topic 720): Fees Paid to the Federal Government by Pharmaceutical Manufacturers.